Pmv Pharmaceuticals Inc share price logo

Pmv Pharmaceuticals Inc

NASDAQ: PMVP

Small Cap

$1.34

-0.07

(-5.28%)

Live

as on

Pmv Pharmaceuticals Inc Stock Performance

as on May 14, 2026 at 4:07 am IST

  • Day's High

    $1.34
    $1.42

    5.97%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.81
    $1.88
    downward going graph

    39.55%

    Downside

    40.30%

    Upside

    downward going graph

Pmv Pharmaceuticals Inc share price movements today

Previous Close
$1.42
Open
$1.40
Volume
612.5K
Day's Low - High
$1.34 - $1.42
52 Week Low - High
$0.81 - $1.88

Pmv Pharmaceuticals Inc Historical Returns

1 Month Return
+ 5.19 %
3 Month Return
+ 27.93 %
1 Year Return
+ 66.63 %
3 Year Return
-75.09 %
5 Year Return
-95.11 %

Pmv Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Check Pmv Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$74.1M

EPS (TTM)

-1.595

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-86.1M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-55.37%

Pmv Pharmaceuticals Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Pmv Pharmaceuticals Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$74.1M-95.11%NA0.00%
BUY$38.0B119.7%71.3912.55%
NA$32.7BNA71.448.94%
BUY$110.4B109.14%25.8435.51%
BUY$74.7B39.88%17.3929.65%

Stock Returns calculator for Pmv Pharmaceuticals Inc Stock including INR - Dollar returns

The Pmv Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Pmv Pharmaceuticals Inc investment value today

Current value as on today

₹1,76,930

Returns

₹76,930

(+76.93%)

Returns from Pmv Pharmaceuticals Inc Stock

₹57,647 (+57.65%)

Dollar Impact

₹19,283 (+19.28%)

Analyst Recommendation on Pmv Pharmaceuticals Inc Stock

Based on 12 analysts

BUY

83.33%

Buy

16.67%

Hold

0.00%

Sell

Based on 12 analysts, 83.33% of analysts recommend a 'BUY' rating for Pmv Pharmaceuticals Inc. Average target price of $4.75

Pmv Pharmaceuticals Inc Share Price Target

Get share price movements and forecasts by analysts on Pmv Pharmaceuticals Inc.

What analysts predicted

71.79%UPSIDE

Target Price

$4.75

Current Price

$1.34

Analyzed by

12 Analysts

Target

$4.75

Pmv Pharmaceuticals Inc target price $4.75, a slight upside of 71.79% compared to current price of $1.34. According to 12 analysts rating.

Indian Investors' Interest in Pmv Pharmaceuticals Inc Stock

Search interest for Pmv Pharmaceuticals Inc Stock has decreased by -5% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-5% versus previous 30 day period

Pmv Pharmaceuticals Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
-
1
-
-
-
-
-
-
-
-
Gross Profit
0
0
0
0
-
-
-
0
0
0
Operating Income
-19
-18
-18
-20
-21
-25
-21
-22
-22
-19
EBITDA
-19
-15
-17
-19
-21
-25
-21
-21
-21
-19
Interest Expense
-
2
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-16
-15
-15
-17
-19
-23
-19
-21
-21
-18
Income Tax Expense
0
0
0
-16
0
-
-2
0
0
0
Net Income
-16
-15
-15
-1
-19
-23
-17
-21
-21
-18
Net Profit Margin
0.00%
-973.79%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Pmv Pharmaceuticals Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
Gross Profit
0
0
0
-1
0
-1
-1
0
Operating Income
-18
-26
-34
-58
-77
-80
-85
-86
EBITDA
-18
-24
-34
-57
-76
-67
-73
-86
Interest Expense
-
1
0
0
4
-
-
-
Depreciation
0
0
0
0
0
0
1
0
Income Before Tax
-17
-25
-34
-57
-73
-68
-74
-79
Income Tax Expense
0
0
0
0
0
0
-16
-2
Net Income
-17
-25
-34
-57
-73
-68
-58
-77
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Pmv Pharmaceuticals Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-15
-15
-1
-19
-23
-17
-21
-21
-18
Operating Cash Flow
-12
-16
-1
-16
-16
-18
-18
-19
-17
Investing Cash Flow
-2
26
2
17
7
28
10
12
18
Financing Cash Flow
0
-
0
-
0
0
0
-
0
Change in Cash
-14
9
0
0
-8
10
-7
-7
1

Pmv Pharmaceuticals Inc Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-25
-34
-57
-73
-68
-58
-77
Operating Cash Flow
-22
-32
-46
-63
-55
-51
-73
Investing Cash Flow
3
27
-143
-1
-50
53
70
Financing Cash Flow
61
292
2
0
35
0
0
Change in Cash
42
288
-188
-64
-70
2
-2

Global Institutional Holdings in Pmv Pharmaceuticals Inc

Funds
Holdings
BML Capital Management LLC
9.92%
Euclidean Capital LLC
4.93%
Two Sigma Advisers, LLC
1.64%
Jane Street Group LLC
0.94%
Assenagon Asset Management SA
0.68%

Insights on Pmv Pharmaceuticals Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, PMVP has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, PMVP stock has moved up by 27.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 32.2% return, outperforming this stock by 107.3%

About Pmv Pharmaceuticals Inc

PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule therapies targeting p53 mutations and other p53-related cancers in the United States. It develops rezatapopt, a selective structural corrector of p53 Y220C mutations in Phase 2 clinical trials for tumor agnostic diseases. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Princeton, New Jersey.
OrganisationPmv Pharmaceuticals Inc
Headquarters400 Alexander Park Drive, Princeton, NJ, United States, 08540
IndustryBiotechnology
CEODr. David H. Mack Ph.D.
E-voting on sharesClick here to vote

Key Management of Pmv Pharmaceuticals Inc

Name

Title

Dr. David H. Mack Ph.D.

Co-Founder, CEO, President & Director

Dr. Arnold J. Levine Ph.D.

Co-Founder, Independent Director & Member of Scientific Advisory Board

Mr. Michael Carulli

Chief Financial Officer

Ms. Crystal Zuckerman

Vice President of Human Resources

Ms. Laura De Leon

VP & Head of Clinical Development Operations

Mr. Robert Ticktin J.D.

General Counsel, COO & Company Secretary

Dr. Deepika Jalota Pharm.D.

Chief Development Officer

Mr. Tim Smith M.B.A.

Senior VP and Head of Corporate Development & Investor Relations

Dr. Binh Vu Ph.D.

Senior Vice President of Drug Discovery & CMC

Dr. Marc Fellous M.D.

Senior VP and Head of Clinical Development & Medical Affairs

FAQs

What is Pmv Pharmaceuticals Inc share price today?

Pmv Pharmaceuticals Inc share price today is $1.34 as on . Pmv Pharmaceuticals Inc share today touched a day high of $1.42 and a low of $1.34.

What is the 52 week high and 52 week low for Pmv Pharmaceuticals Inc share?

Pmv Pharmaceuticals Inc share touched a 52 week high of $1.88 on and a 52 week low of $0.81 on . Pmv Pharmaceuticals Inc stock price today i.e. is trending at $1.34,which is 28.72% down from its 52 week high and 65.43% up from its 52 week low.

What is Pmv Pharmaceuticals Inc's market capitalisation today?

Pmv Pharmaceuticals Inc market capitalisation is $0.00T as on .

How to invest in Pmv Pharmaceuticals Inc Stock (PMVP) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Pmv Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Pmv Pharmaceuticals Inc Shares that will get you 1.1194 shares as per Pmv Pharmaceuticals Inc share price of $1.34 per share as on May 13, 2026 at 10:37 pm IST.

What is the minimum amount required to buy Pmv Pharmaceuticals Inc Stock (PMVP) from India?

Indian investors can start investing in Pmv Pharmaceuticals Inc (PMVP) shares with as little as ₹95.705 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹957.05 in Pmv Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Pmv Pharmaceuticals Inc share’s latest price of $1.34 as on May 13, 2026 at 10:37 pm IST, you will get 7.4627 shares of Pmv Pharmaceuticals Inc. Learn more about fractional shares .

What are the returns that Pmv Pharmaceuticals Inc has given to Indian investors in the last 5 years?

Pmv Pharmaceuticals Inc stock has given -95.11% share price returns and 29.72% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?